🔎 Trials Near Me

Početna › Alopecia areata › Texas

Kliničke studije za Alopecia areata u državi Texas

7 studija za Alopecia areata traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

  • 3A Research - East location /ID# 283404, El Paso
  • Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07772492

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

  • Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 50 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07533006

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  • The University of Texas Health Science Center at Houston, Bellaire
  • Center for Clinical Studies, Houston
  • Center for Clinical Studies - Clear Lake, Webster
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06873945

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

  • Center for Clinical Studies, LTD. LLP, Houston
  • Texas Dermatology and Laser Specialists, San Antonio
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT07733765

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

  • Arlington Research Center, Inc /ID# 258028, Arlington
  • Bellaire Dermatology Associates /ID# 259360, Bellaire
  • Dfw Clinical Trials /ID# 284604, Carrollton
  • i još 5
U tijeku regrutacijaFaza 3
Od 12 do 63 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06012240

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

  • 3A Research, El Paso
  • Texas Dermatology and Laser Specialists, San Antonio
U tijeku regrutacijaFaza 3
Od 6 do 14 godina · Oba spola · Ažurirano 28. tra 2026. · NCT07029828

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  • Dermatology Treatment And Research Center - Dallas, Dallas
  • North Texas Center For Clinical Research, Frisco
  • Austin Institute For Clinical Research Inc., Pflugerville
  • i još 1
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 28. sij 2026. · NCT07133308

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.